UDP glucuronosyltransferase family 2 member B29, pseudogene (UGT2B29P)

**UDP glucuronosyltransferase family 2 member B29, pseudogene (UGT2B29P)** is a human pseudogene, designated with the official gene symbol "UGT2B29P"[4]. It belongs to the broader family of UDP-glucuronosyltransferase genes, which are involved in phase II metabolism—specifically catalyzing glucuronidation reactions essential for detoxification and elimination of endogenous and exogenous compounds in other, functional members of the UGT family[3]. However, as a pseudogene, UGT2B29P is not known to produce a functional protein product, nor is it implicated in therapeutic targeting, clinical pharmacology, or disease. Its sequence may be used as a reference for evolutionary or comparative genetics, but no biological, pharmacological, or disease relevance has been reported for this locus[4]. UGT2B29P is not a functional protein-coding gene and is not a therapeutic target. Its classification as a pseudogene distinguishes it from active enzymes within the UGT2 family, including UGT2B4 and UGT2B7, which play important roles in drug and hormone metabolism[1][3][5]. There is no known role in disease, therapy, drug interaction, or safety for UGT2B29P[4].